Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
The "insider return" statistic is based on the return generated (during the period shown) by a portfolio consisting of long positions in the stock corresponding to each purchase and short positions for each sale. The "insider grade" is calculated by testing the statistical significance of the timing of the insiders' trades; a grade of A means that if the same trades were made with random timing, there would be no more than a 5% chance of exceeding the insiders' return.
| Date | Insider | Relationship | Transaction Type | Number of Shares | Price | Market Value |
|---|---|---|---|---|---|---|
| 220 found. 1 through 20 displayed. 1 2 3 4 5 6 7 8 9 10 11 [Next] | ||||||
| 3/15/2013 | William Anthony Vernon, MBA | Director | S | 60,000 | 45.91 | $2,754,600 |
| 3/15/2013 | William Anthony Vernon, MBA | Director | M | 30,000 | 6.97 | $209,100 |
| 3/15/2013 | William Anthony Vernon, MBA | Director | M | 30,000 | 9.38 | $281,400 |
| 3/07/2013 | Kim D. Blickenstaff MBA, CPA | Director | S | 13,500 | 47.88 | $646,380 |
| 3/07/2013 | Kim D. Blickenstaff MBA, CPA | Director | S | 31,300 | 46.92 | $1,468,596 |
| 3/07/2013 | Kim D. Blickenstaff MBA, CPA | Director | S | 15,200 | 46.18 | $701,936 |
| 3/07/2013 | Kim D. Blickenstaff MBA, CPA | Director | M | 60,000 | 9.38 | $562,800 |
| 1/31/2013 | Kathryn E. Falberg MBA, CPA | Director | A | 7,500 | 0.00 | $0 |
| 12/07/2012 | David T. Hung, MD | President & Chief Executive Officer | S | 5,315 | 54.78 | $291,156 |
| 12/07/2012 | David T. Hung, MD | President & Chief Executive Officer | S | 4,931 | 54.03 | $266,422 |
| 12/07/2012 | David T. Hung, MD | President & Chief Executive Officer | A | 31,000 | 0.00 | $0 |
| 12/07/2012 | Lynn Seely, MD | Chief Medical Officer | A | 9,000 | 0.00 | $0 |
| 12/07/2012 | Clarence Patrick Machado | Chief Financial & Business Officer | D | 2,660 | 54.78 | $145,715 |
| 12/07/2012 | Clarence Patrick Machado | Chief Financial & Business Officer | D | 2,465 | 54.00 | $133,110 |
| 12/07/2012 | Clarence Patrick Machado | Chief Financial & Business Officer | A | 9,000 | 0.00 | $0 |
| 12/07/2012 | Cheryl L. Cohen | Chief Commercial Officer | A | 9,000 | 0.00 | $0 |
| 10/30/2012 | Gregory H. Bailey, MD | Director | M | 9,374 | 11.00 | $103,114 |
| 10/30/2012 | Gregory H. Bailey, MD | Director | M | 17,498 | 4.42 | $77,341 |
| 10/30/2012 | Gregory H. Bailey, MD | Director | M | 24,999 | 11.21 | $280,239 |
| 10/30/2012 | Gregory H. Bailey, MD | Director | M | 30,000 | 6.97 | $209,100 |
